Sernova Biotherapeutics Inc (FRA:PSH0)
0.0825
+0.0010 (1.23%)
At close: Jan 9, 2026
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of €30.2 million as of January 9, 2026. Its market cap has decreased by -39.57% in one year.
Market Cap
30.20M
Enterprise Value
32.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 12.10M to 30.20M, an increase of 149.61%. That is a compound annual growth rate of 3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 30.20M | 11.09% |
| Dec 31, 2025 | 27.19M | -45.20% |
| Dec 31, 2024 | 49.62M | -67.75% |
| Dec 29, 2023 | 153.86M | -3.89% |
| Dec 30, 2022 | 160.10M | -51.52% |
| Dec 31, 2021 | 330.23M | 266.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |